Zobrazeno 1 - 10
of 1 243
pro vyhledávání: '"S. Monfardini"'
Autor:
Giuseppe Colloca, A. Bellieni, D. Fusco, F. Benvenuto, S. Bracci, E. Villani, B. Di Capua, F. Marazzi, L. Tagliaferri, L. Balducci, S. Monfardini, V. Valentini
Publikováno v:
Annals of Clinical Oncology. :1-4
The SARS-CoV-2 pandemic has led us to imagine the current scenario as something terrible, disastrous, but temporary. However, history teaches us that an event of this magnitude can only evolve towards “new” normality, a new equilibrium, but it wi
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 1 (2007)
Oxaliplatin plus 5Fluorouracil (5FU) and leucovorin (LV) is the standard treatment of metastatic colorectal cancer (CRC). We describe a rare clinical case of acute renal failure probably oxaliplatin-related at one day from the end of the palliative t
Externí odkaz:
https://doaj.org/article/063be2fd25c24df7855ba609faedc8ce
Publikováno v:
Italian Journal of Food Safety, Vol 1, Iss 4, Pp 99-100 (2012)
The aim of this study was to evaluate the inhibitory effect of biocides on S.aureus strains isolated in dairy environment. After a contact time of 5' all tested molecules showed total growth inhibition of bacteria; for lower contact time results were
Externí odkaz:
https://doaj.org/article/d7cf515596b049118df43d3bbef5ba43
Autor:
Giuseppe Renne, Sandra Thierstein, Ugo Pace, S. Cenciarelli, M.G. Zampino, Bruno Andreoni, M. Matter, Simonetta Pozzi, Arnaud Roth, F. de Braud, S. Mura, A. Goldhirsch, Olivier Huber, S. Boselli, Cristiano Crosta, G. Di Meglio, Juerg Bernhard, Roger Stupp, Stefanie Hayoz, Rudolf Maibach, Christian Dittrich, Peter Brauchli, Fabrizio Luca, M. Richter, Nicola Fazio, S. Monfardini, Antonio Chiappa, Rudolf Morant, Davide Ravizza, Emilio Bertani, Roberto Biffi, M. Häfner, K. Lorizzo, M. Clemens
Publikováno v:
Annals of Oncology. 27:668-673
Background Fluorouracil-based adjuvant chemotherapy in gastric cancer has been reported to be effective by several meta-analyses. Perioperative chemotherapy in locally advanced resectable gastric cancer (RGC) has been reported improving survival by t
Publikováno v:
Personalized Management of Breast Cancer. :100-118
Autor:
Tesema, Getayeneh Antehunegn1,2 (AUTHOR), Stirling, Rob G.3,4 (AUTHOR), Tessema, Zemenu Tadesse1,2 (AUTHOR), Heritier, Stephane1 (AUTHOR), Earnest, Arul1 (AUTHOR) arul.earnest@monash.edu
Publikováno v:
Cancer Medicine. Oct2024, Vol. 13 Issue 19, p1-13. 13p.
Autor:
S. Monfardini, M. Aapro
Publikováno v:
Oncologie. 9:238-244
La Societe internationale d’oncologie geriatrique (SIOG) cherche a promouvoir dans le monde entier une prise en charge du patient âge basee sur des considerations scientifiques. Afin de developper les approaches therapeutiques d’une facon cohere
Autor:
U. Tirelli, E. Vaccher, A. Lazzarin, E. Alessi, I. Crosato, F. Milazzo, A. Cargnel, D. Greco, F. Aiuti, M. Moroni, S. Monfardini
The Italian Cooperative Group on AIDS & Tumors (GICAT) is collecting data on the epidemiological and clinical features of Kaposi's sarcoma (KS) in Italy, a country where intravenous drug users (IVDUs) comprise the largest group affected by AIDS. As o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ced3412691e3290946d2229dddcdc39c
https://doi.org/10.1159/000419724
https://doi.org/10.1159/000419724
Autor:
Mario Lise, E. Urso, S. Monfardini, G. Fabris, Guido Sotti, Maria Luisa Friso, L. Sartor, Salvatore Pucciarelli, Carlo Aschele, Sara Lonardi, P. Del Bianco
Publikováno v:
Annals of Oncology. 16:1140-1146
Background: Oxaliplatin (OXA) significantly enhanced the antitumour activity of 5-fluorouracil (FUra) in patients with advanced colorectal cancer and displayed radiosensitising properties in preclinical studies. This study was thus performed to test
Autor:
Francesca Vastola, M. Ermani, Antonio Jirillo, S. Monfardini, Sara Lonardi, Alicia Tosoni, Haralabos Koussis, Alba A. Brandes, M. K. Paris, L. M. Pasetto, Umberto Basso
Publikováno v:
Annals of Oncology. 14:1727-1731
Background This study was a phase II study of third-line chemotherapy with carboplatin plus teniposide in patients with recurrent oligodendroglioma. Patients and methods Patients with oligodendroglioma progressive or recurrent after surgery, radiothe